162 related articles for article (PubMed ID: 11292998)
1. Cardiovascular risk in women with polycystic ovary syndrome.
Talbott EO; Zborowski JV; Sutton-Tyrrell K; McHugh-Pemu KP; Guzick DS
Obstet Gynecol Clin North Am; 2001 Mar; 28(1):111-33, vii. PubMed ID: 11292998
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease risk factors in polycystic ovary syndrome.
Dokras A
Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
[TBL] [Abstract][Full Text] [Related]
3. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.
Talbott EO; Zborowskii JV; Boudraux MY
Minerva Ginecol; 2004 Feb; 56(1):27-39. PubMed ID: 14973408
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study.
Wild S; Pierpoint T; McKeigue P; Jacobs H
Clin Endocrinol (Oxf); 2000 May; 52(5):595-600. PubMed ID: 10792339
[TBL] [Abstract][Full Text] [Related]
5. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women.
Talbott EO; Guzick DS; Sutton-Tyrrell K; McHugh-Pemu KP; Zborowski JV; Remsberg KE; Kuller LH
Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2414-21. PubMed ID: 11073846
[TBL] [Abstract][Full Text] [Related]
6. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
7. Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?
Gunning MN; Fauser BCJM
Climacteric; 2017 Jun; 20(3):222-227. PubMed ID: 28457146
[TBL] [Abstract][Full Text] [Related]
8. Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study.
Chang AY; Oshiro J; Ayers C; Auchus RJ
Clin Endocrinol (Oxf); 2016 Jul; 85(1):92-9. PubMed ID: 26608823
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro RS
Endocr Rev; 2003 Jun; 24(3):302-12. PubMed ID: 12788801
[TBL] [Abstract][Full Text] [Related]
10. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.
Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC
Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959
[TBL] [Abstract][Full Text] [Related]
11. Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors.
Shi Y; Cui Y; Sun X; Ma G; Ma Z; Gao Q; Chen ZJ
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():66-70. PubMed ID: 24368020
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk and events in polycystic ovary syndrome.
Carmina E
Climacteric; 2009; 12 Suppl 1():22-5. PubMed ID: 19811236
[TBL] [Abstract][Full Text] [Related]
13. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome.
Lambrinoudaki I
Maturitas; 2011 Jan; 68(1):13-6. PubMed ID: 20943333
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular health in women with polycystic ovary syndrome.
Sukalich S; Guzick D
Semin Reprod Med; 2003 Aug; 21(3):309-15. PubMed ID: 14593554
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis.
Mak W; Dokras A
Semin Thromb Hemost; 2009 Oct; 35(7):613-20. PubMed ID: 20013528
[TBL] [Abstract][Full Text] [Related]
17. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
18. Does cardiovascular risk vary according to the criteria for a diagnosis of polycystic ovary syndrome?
Ramoglu S; Yoldemir T; Atasayan K; Yavuz DG
J Obstet Gynaecol Res; 2017 Dec; 43(12):1848-1854. PubMed ID: 28892255
[TBL] [Abstract][Full Text] [Related]
19. Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?
Loucks TL; Talbott EO; McHugh KP; Keelan M; Berga SL; Guzick DS
Fertil Steril; 2000 Sep; 74(3):547-52. PubMed ID: 10973653
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.
Lo JC; Feigenbaum SL; Yang J; Pressman AR; Selby JV; Go AS
J Clin Endocrinol Metab; 2006 Apr; 91(4):1357-63. PubMed ID: 16434451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
